NATKO PHARMA LIMITED
UkraineAll drugs from this manufacturer
-
The drug is used to treat metastatic breast cancer, progressive ovarian cancer, multiple myeloma (in combination with bortezomib), as well as AIDS-associated Kaposi's sarcoma.
Dosage form: concentrate for infusion solution, liposomal
Active substance Dosage doxorubicin 2 mg/ml ATC: L01DB01